Table 2. Performance metrics at various neutrophil-to-lymphocyte ratio (NLR) cutoff values for predicting advanced stage (stages III and IV) breast cancer.
| Baseline NLR cutoff | 2.5 cut off value | 3.0 cut off value | 3.5 cut off value |
| True positive (TP) | 19 | 7 | 12 |
| True negative (TN) | 4 | 28 | 12 |
| False positive (FP) | 31 | 7 | 23 |
| False negative (FN) | 2 | 14 | 9 |
| Sensitivity | 90.5% | 33.3% | 57.1% |
| Specificity | 11.4% | 80.0% | 34.3% |
| Accuracy | 41.1% | 62.5% | 42.9% |
| PPV | 38.0% | 50.0% | 34.3% |
| NPV | 66.7% | 66.7% | 57.1% |
| Youden’s J index | 0.019 | 0.133 | -0.086 |